A team of researchers from Nanyang Technological University, Singapore (NTU Singapore), Ngee Ann Polytechnic, Singapore (NP), and the National Heart Centre Singapore (NHCS) have invented a tool that could speed up the diagnosis of cardiovascular diseases.

Powered by artificial intelligence (AI), their innovation uses electrocardiograms (ECGs) to  diagnose coronary artery disease, myocardial infarction and congestive heart failure to an accuracy of more than 98.5 per cent.

The joint development of the diagnostic tool is timely, as the number of deaths caused by cardiovascular disease in Singapore has increased over the past three years.  According to the Singapore Heart Foundation, 29.3 per cent of all deaths in Singapore in 2019, or almost 1 out of 3 deaths in Singapore, was due to heart diseases or stroke.

The scientists hope that their innovation could support the diagnosis of cardiovascular diseases in clinical settings, specifically while physicians carry out preliminary ECGs, ultimately leading to speedier courses of treatment.

Previous NUS Researchers Develop World’s First Blood Test For Real-Time Monitoring Of Cancer Treatment Success
Next Imagine Cup 2021: Getting To The Root Of Food Insecurity

Suggested Posts

Singapore’s Changi Terminal 5: Looking Ahead

Supporting National Efforts To Stay Home, Go Digital, And Stem COVID-19 Infections

Singapore Passport Ranked Most Powerful Again According To Henley & Partners Passport Index

Here’s Why The WHO Says A Coronavirus Vaccine Is 18 Months Away